ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/08/2023
Back to search
Official data from USPTO
BIOPTRON HYPERLIGHT THERAPY SYSTEM BY ZEPTER GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOPTRON HYPERLIGHT THERAPY SYSTEM BY ZEPTER GROUP
ST13
US500000090242495Class
44
Filing
90242495
Registration
6631373
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/08/2023
Trademark type
Word
Nice classes
44
Filing date
10/08/2020
Registration date
02/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/01/2022
Last transaction
02/01/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
NICOSIA, CY
Examiner
LEHKER, DAWN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
FIELDPOINT (CYPRUS) LIMITED
Fieldpoint B.V.
Representatives
Michael T. Hess SEAGER, TUFTE & WICKHEM LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical therapeutic servicesstimulation of biological processes by irradiationin particular with polarized light or laser beams for the treatment of injuries and other therapeutic applicationsfor the stimulation of microbiological processes and germination capacity by means of irradiation with the aforesaid light and laser beams
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/01/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/29/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/29/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/22/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/22/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2021
PUBO
PUBLISHED FOR OPPOSITION
05/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/18/2021
GPRA
PRIORITY ACTION E-MAILED
03/18/2021
CPRA
PRIORITY ACTION WRITTEN
03/18/2021
DOCK
ASSIGNED TO EXAMINER
03/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/23/2020
NWAP
NEW APPLICATION ENTERED
10/12/2020
Continuous trademark protection
Get notified about every new filing that threatens BIOPTRON HYPERLIGHT THERAPY SYSTEM BY ZEPTER GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.